[1]
“CUT OFF VALUE OF PROCALCITONIN IN END STAGE RENAL DISEASE PATIENTS WITHOUT INFECTION”, Pak J Kidney Dis, bd. 5, nr. 02, s. 48–53, jun. 2021, doi: 10.53778/pjkd502144.